Updated August 31 at 6:31pm
Biotechnology
43 results total, viewing 11 - 20
(Updated, 5:40 p.m.) Ximedica announced Tuesday it has purchased the San Francisco-based Bridge Design, providing the Rhode Island-based medical technology development company with a West Coast hub. more
The first two patients in IlluminOss Medical Inc.’s U.S. Lightfix clinical trial for the treatment of impending and pathologic fractures have been successfully treated at the Marshall University Joan C. Edwards School of Medicine. more
The co-founder and president of MedMates, Rhode Island’s first health care technology network group, and co-founder and director of an emerging health-tech company, Aspiera Medical, talks about starting a company in Rhode Island and what he expects MedMates to look like down the road. more
A Cherrystone Angel Group portfolio company, Windgap Medical Inc., was awarded nearly $1 million through a Massachusetts Life Sciences Center accelerator loan program. more
Mnemosyne Pharmaceuticals Inc. appointment of Vanessa King as president and CEO. more
IlluminOss Medical has been issued two patents related to its internal bone fixing system, the company announced Tuesday. more
Brown University has leased its 4,000-square-foot building at 349 Eddy St. to biotechnology firm ProThera Biologics. more
The U.S. Treasury Department has released $4.3 million, the second tranche of a $13.1 million State Small Business Credit Initiative grant awarded to Rhode Island four years ago, to support the Slater Technology Fund’s SSBCI program. more
NsGene Inc.’s innovative brain-repair therapy couldn’t have come at a better time, as one of the neurodegenerative diseases it would treat – Parkinson’s disease – has gotten a lot of press lately. more
IlluminOss Medical has received conditional approval from the federal Food and Drug Administration to conduct a clinical trial for treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »